Scientists are developing more than 100 coronavirus vaccines using a range of techniques, some of which are well-established and some of which have never been approved for medical use before.
Most of these vaccines target the so-called spike proteins that cover the virus and help it invade human cells. The immune system can develop antibodies that latch onto spike proteins and stop the virus.
By Jonathan Corum, Knvul Sheikh and Carl Zimmer
Our site uses cookies to personalize features and, via third-parties, to collect metrics on usage so that we can better tailor our site to the needs of our users. You can view our full cookie and privacy policies via the links below. To fully experience our site, please click Accept.
